The Centers for Disease Control and Prevention (CDC) warns that while the risk of human to human transmission remains low, experts and officials must be aware of the risk that mutations in the virus ...

Avian influenza viruses typically require several mutations to adapt and spread among humans, but what happens when just one change can increase the risk of becoming a pandemic virus? A recent study ...

DURHAM, N.C. -- Researchers at Duke University's School of Medicine helped discover a new strain of coronavirus. Dr. David Montefiori, a professor of surgery who also serves as Director of the ...

Early in the beginning of the COVID-19 pandemic, scientists predicted the coronavirus would mutate slowly. They were wrong. Hundreds of thousands of viral mutations and multiple seasonal waves later, ...

An aggressive strain of the H3N2 virus is overwhelming emergency medical services in southern Florida. Experts warn that low ...

Please provide your email address to receive an email when new articles are posted on . Since May 2023, a combination of neuraminidase mutations has been detected in influenza A(H1N1)pdm09 viruses.

Huge die-offs of elephant seals occurred after the virus gained nearly 20 troublesome new mutations, scientists found. By Apoorva Mandavilli Elephant seals in South America died in massive numbers ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

This month’s story comes from the Bloom lab using their signature deep mutational scanning technique to identify mutations in the surface protein of Lassa virus -called glycoprotein- that escape ...

Combined infection with bird flu and human flu could lead to mutations of new viruses that could have dangerous public health consequences, agencies have warned. This is following the news that ...

There are currently two approved COVID-19 treatments that can be taken orally: nirmatrelvir-ritonavir (known as Paxlovid and developed by Pfizer) and Merck’s molnupiravir. They have both been shown to ...